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Abstract
Information sources about prostate cancer treatment and outcomes are typically designed for 
patients. Little is known about the availability and utility of information for partners. The 
objectives of our study were to evaluate information sources used by partners to understand 
prostate cancer management options, their perceived usefulness, and the relationship between 
sources used and satisfaction with treatment experience. A longitudinal survey of female partners 
of men newly diagnosed with local-stage prostate cancer was conducted in three different 
geographic regions. Partners and associated patients were surveyed at baseline (after patient 
diagnosis but prior to receiving therapy) and at 12 months following diagnosis. Information 
sources included provider, literature, friends or family members, Internet websites, books, 
traditional media, and support groups. Utility of an information source was defined as whether the 
partner would recommend it to caregivers of other patients with local-stage prostate cancer. Our 
study cohort included 179 partner-patient pairs. At diagnosis, partners consulted an average of 4.6 
information sources. Non-Hispanic white partners were more likely than others to use friends and 
family as an information source (OR = 2.44, 95% CI (1.04, 5.56)). More educated partners were 
less likely to use support groups (OR = 0.31, 95% CI (0.14, 0.71)). At 12-month follow-up, 
partners were less likely to recommend books (OR = 0.23, 95% CI (0.11, 0.49)) compared to 
baseline. Partners consulted a large number of information sources in researching treatment 
options for local-stage prostate cancer and the types of sources accessed varied by race/ethnicity 
and educational attainment. Additional resources to promote selection of high-quality non-
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provider information sources are warranted to enable partners to better aid patients in their 
treatment decision-making process.
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Introduction
Common treatment options for local-stage prostate cancer include active surveillance, 
radical prostatectomy, brachytherapy, external beam radiation, and hormone therapy. While 
the 5-year survival rate for local-stage prostate cancer exceeds 99% [1], many men 
experience long-term, adverse effects as a result of treatment [2]. Despite the prevalence of 
prostate cancer, there is limited comparative data on treatment efficacy and no consensus on 
what primary treatment constitutes the optimal treatment strategy for patients diagnosed 
with local-stage disease [3–5]. Partners may play a key role in collecting and processing 
information on management options for patients and evaluating the treatment-related side 
effects [6, 7].
Partners of newly diagnosed prostate cancer patients are often encouraged to engage in a 
shared decision-making approach with the patient and provider to determine the optimal 
treatment for the patient. Although the information needs of men diagnosed with prostate 
cancer have been previously reported [8, 9], there is limited literature on the information 
needs of partners [10]. Previous studies have shown that partners often pursue a more active 
coping strategy in the pretreatment phase than patients who may still be in a state of shock 
following their prostate cancer diagnosis [11]. Men who are distressed by the need to make a 
treatment decision report being unable to engage in active coping strategies such as 
information seeking and may be more reliant on their partner for sharing information and 
initiating the treatment discussion [12, 13].
Little is also known about the types of information sources partners use, whether they 
perceived this information as useful, and of the role that these information sources played in 
partner’s satisfaction with the treatment process, particularly when their spouse experienced 
adverse outcomes (e.g., urinary incontinence, sexual dysfunction) following treatment. The 
literature on cancer survivors provides strong evidence that access to information facilitates 
treatment decision-making and provides a host of benefits to both the patient and partner 
[14]. Although these benefits are not as well characterized in partners, in patients, access to 
information leads to a more active coping strategy [15], decreased anxiety and distress [16], 
improved communication with family members [17, 18], and increased satisfaction with 
treatment choice [19, 20]. In this study, we evaluated the idea that the relationship between 
information sources, perceived usefulness, and satisfaction for patients is similar for 
partners.
In the current study, we evaluated (1) information sources used by partners to understand 
prostate cancer management options and possible treatment-related outcomes, (2) perceived 
usefulness of information sources 12 months after diagnosis, and (3) the relationship 
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between number of information sources used and satisfaction with treatment experience. We 
hypothesized that high ratings of usefulness at baseline and follow-up were associated with 
higher levels of satisfaction at follow-up, even for partners of men who experienced side 
effects of therapy.
Materials
Study Design
We conducted a longitudinal study using data from the Family And Cancer Therapy 
Selection (FACTS) study, evaluating partner survey responses at baseline (at time of patient 
diagnosis) and 12-month follow-up. Recruitment procedures and patient eligibility have 
been described elsewhere [21]. In brief, newly diagnosed prostate cancer patients were 
recruited from academic urology clinics in CA, SC, and TX. Eligible patients included those 
diagnosed with incident localized prostate cancer (American Joint Cancer Committee stages 
I–III, TNM stages T1–T2, N0, M0, PSA ≤ 50) that had not initiated treatment other than 
hormone therapy at the time of approach.
Study coordinators conducted patient and partner recruitment at clinic sites at the end of the 
patient’s treatment consultation visit. Patients enrolled to the study were asked to nominate a 
family member to participate in the associated partner study. Of the family members 
identified by the patient, 93% were female spouses or partners [21]. As a result, we chose to 
restrict the linked study to female partners only for this analysis. Patients and partners who 
opted to participate signed consent forms and received a baseline take-home survey to return 
by mail in a self-addressed stamped envelope. Partners who did not attend the initial 
consultation were mailed a study approach letter, consent form, and baseline survey.
Study staff mailed out follow-up surveys to patients and partners 12 months from enrollment 
in the study and conducted follow-up phone calls to maximize survey response at this 
follow-up survey time point. Participants received $25 after completing the baseline survey 
and after completing the follow-up survey.
The study protocol and materials were approved by the institutional review board at each 
recruitment center, the coordinating center at the Fred Hutchinson Cancer Research Center 
in Seattle, WA, and the human subjects review committee at the Centers for Disease Control 
and Prevention.
Survey Items
Baseline partner surveys included sociodemographic characteristics, type of information 
sources used in treatment decision-making, treatment options considered, treatments 
recommended by the physician, and the treatment outcomes that may be important to 
partners of a prostate cancer patient. The partner baseline survey also collected information 
on the partner’s role in the information gathering and treatment decision-making process. 
The information sources listed in the survey included (1) type of provider seen based on 
treatment received (e.g., doctor who performed biopsy, surgery, radiation therapy); (2) 
literature provided by physicians (pamphlets, videos, lectures) and medical journals; (3) 
friends or family members diagnosed with prostate cancer; (4) online websites (e.g., 
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hospital, national cancer organizations, or other websites); (5) books about prostate cancer; 
(6) traditional media (e.g., newspaper, magazines, television, or radio); and (7) support 
groups (in-person or on the Internet). Patients and partners were asked to rate how helpful 
each information source was on a 5-point Likert scale ranging from not helpful to very 
helpful. The 12-month follow-up partner survey assessed the impact of cancer on the 
patient’s life, the treatment-related side effects, and the utility of the information source, 
defined as whether they would recommend the information source to family members of 
patients with local-stage prostate cancer. Finally, we included questions asking partners to 
rate their satisfaction with the patient’s doctor and the treatment outcome. Survey questions 
were generated for the purposes of this study.
Analysis
A total of 179 partner-patient pairs completed the baseline survey. We tabulated summary 
statistics of partner sociodemographic characteristics and the number and type of 
information sources consulted at the time of the baseline survey.
For each information source, we explored partner characteristics associated with using that 
particular source. A separate multivariate logistic regression model was fit for each source. 
The outcome was whether the source was used at baseline and the predictors included 
partner age, race/ethnicity (non-Hispanic white vs all other), and education.
Next, among those who completed both baseline and follow-up surveys, we assessed 
whether the partners’ perception of helpfulness of each information source changed between 
baseline and 12 months (determined by whether the partner would recommend the source at 
12 months). A separate multivariate logistic regression model was fit for each source, among 
partners who used that source at baseline. We used robust variance estimation to account for 
the correlation due to repeated measurements on the same partners.
Finally, we assessed the relationship between number of information sources used at 
baseline and satisfaction with care at 12-month follow-up. We fit two separate multivariate 
logistic regression models using the following dependent variables: (1) partners’ overall 
level of satisfaction with the patients’ prostate cancer doctors and (2) partners’ satisfaction 
with the treatment outcome, reflecting the partners’ responses to the following questions:
• Please rate your overall level of satisfaction with your loved one’s prostate 
cancer doctors
• How do you feel your loved one’s treatment (or watchful waiting) has worked 
out?
Responses were recorded on a 5-point Likert scale with the following categories: completely 
satisfied, very satisfied, somewhat satisfied, not at all satisfied, and not sure. For this 
analysis, the dependent variable was recorded as a 1 if the response was “completely” or 
“very” satisfied and 0 otherwise. We adjusted for partner age, partner race/ethnicity, partner 
education, and recruitment site.
Statistical analyses were performed using R statistical software (version 3.2.1). Reported p 
values are two-sided and significance of test was considered when p < 0.05.
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Results
A total of 315 family members were approached for participation at the time of patient 
diagnosis. Of the family members approached, 122 were excluded from the analyses for the 
following reasons: non-response to the baseline survey (n = 83), ineligible due to patient 
identified by the partner not participating in a companion survey (n = 27), and refusal to 
participate or not interested (n = 12). We removed an additional 14 family members from the 
analysis who reported not being the wife or female partner of the patient. Of the 179 partners 
who returned the baseline survey, 93 (52%) completed a 12-month follow-up survey.
Table 1 summarizes baseline partner demographic characteristics and information use. 
Among partners who completed the baseline survey, the average age (range 40–84 years) 
was 59.1 (SD 8.7), 69% were <65 years of age, 70% were non-Hispanic white, and 48% 
were college graduates. At baseline, partners consulted an average of 4.6 (SD 1.5) 
information sources to inform treatment decision-making. Partners reported providers as the 
most commonly used information source (99%), followed by the literature (80%), friends or 
family members diagnosed with prostate cancer (78%), and online sites (65%).
Table 2 shows the associations between partner characteristics and use of information 
sources other than doctors at baseline. Non-Hispanic white partners were more likely than 
others to use friends and family diagnosed with prostate cancer as an information source 
(OR = 2.44, 95% CI (1.04, 5.56)). Partners who were more educated were less likely to use 
face-to-face or Internet support groups as an information source (OR = 0.31, 95% CI (0.14, 
0.71) than partners with lower levels of education.
Table 3 compares partners’ views of helpfulness of information sources at baseline and at 
12-month follow-up, among those who completed both surveys. Partners at baseline rated 
providers as the most helpful information source (97% of partners), followed by literature 
(92%), friends or family members (92%), and Internet websites (90%) as the most helpful 
information sources. At baseline, 84% reported they had received enough information to 
understand the issues involved in making a treatment decision. Among partners who 
completed the 12-month follow-up survey, the proportions of those who would recommend 
the same information sources at 12 months generally declined or remained the same with the 
exception of Internet or face-to-face support groups (Table 3). We note that 12-month data 
on providers were not available, as they were not listed as an information source in the 12-
month survey. There was a statistically significant decline in books viewed as a helpful 
information source at 12-month follow-up compared to baseline (OR 0.23; 95% CI (0.11, 
0.49)). Traditional media was also viewed as less helpful at 12-month follow-up compared 
to baseline, although this association was not statistically significant (OR 0.51; 95% CI 
(0.25, 1.02)).
Finally, among partners who completed both surveys, no association was found between 
number of information sources used at baseline and satisfaction with care at 12-month 
follow-up. For partners’ overall level of satisfaction with the patients’ prostate cancer 
doctors, we estimated an adjusted odds ratio of 1.19 (95% CI (0.78, 1.80)). For partners’ 
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satisfaction with the treatment outcome, we estimated an adjusted odds ratio of 0.84 (95% 
CI (0.56, 1.26)).
Discussion and Conclusion
Discussion
Although many partners play an active role in prostate cancer patients’ decisions regarding 
their care, there is limited literature on the informational needs of partners and how they 
perceive the usefulness of information that they access over time. This prospective, multi-
site survey provides some useful insights about baseline and 12-month assessments of 
perceived helpfulness of information sources. Partners accessed a relatively large number of 
information sources around the time of their loved one’s diagnosis and the types of sources 
accessed varied by race/ethnicity and educational attainment. Books and traditional media 
were seen as less helpful in retrospect compared to the time nearest the patient’s diagnosis. 
By comparison, however, Internet or face-to-face support groups were more likely to be 
recommended by partners at 12 months than at baseline. Satisfaction with the treatment 
experience was not associated with information sources accessed.
Partners often have the responsibility of gathering information about diagnosis and treatment 
options, as well as a role in treatment decision-making. A previous study by Rim et al. using 
the FACTS cohort evaluated how family members (partners) viewed their role in treatment 
decision-making [6]. In this study, 97% of family members “strongly agreed” that their role 
was to listen and provide emotional support, while 82% of partners “strongly agreed” that 
their role was to help collect information about cancer and treatment options. These findings 
suggest that partners play an active role in gathering information, presumably so they can 
provide informed support to the patient and assist the patient in his treatment decision-
making. In this survey, the great majority of partners (84%) felt that they received enough 
information to understand the issues involved in making a treatment decision, suggesting 
that as a whole, there is sufficient accessible information to support partners in their 
perceived roles.
There is a growing body of evidence to suggest that partners engage in a process of 
information seeking that is often more active than patients, in part, because partners may 
seek a broader understanding of the entire cancer experience compared to men with more 
focused information needs [22]. Furthermore, partners are more likely to exhibit high 
information-seeking behavior and collect disease and treatment information on behalf of the 
patient as an active coping strategy [7]. Partners’ primary motivations for seeking 
information include reducing feelings of anxiety and uncertainty, facilitating treatment 
decision-making, helping to care for the patient, and ensuring their own information needs 
are met [23]. A pilot study found a significant and positive relationship between 
participants’ information-seeking behavior and their need for information [10]. This finding 
suggests that both patients and partners benefit from accessing information during the 
treatment decision-making process. Health care providers can support the needs of the 
patient and partner by identifying whether they are satisfied with the available information 
or seek additional information and resources. Accordingly, providers can help the patient 
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and partner navigate educational materials and resources based on their information needs 
and preferences.
To our knowledge, no studies have examined the preferences for specific information 
sources, perceived usefulness, and treatment decision-making needs that exist from a partner 
perspective. Research examining information seeking and prostate cancer has primarily 
examined the information sources used by newly diagnosed men and how to address their 
treatment-related concerns [22, 24]. Relatively few studies have reported on the perceived 
helpfulness of information sources used by patients or partners.
Our findings indicate that partners are more likely to report Internet or face-to-face support 
groups as helpful at 12-month follow-up compared to the time period between diagnosis and 
treatment (baseline). Ramsey et al. surmised that face-to-face support groups are oriented 
towards helping patients cope with their disease during and after treatment, rather than prior 
to treatment [25]. Another qualitative study showed that partners desired more emotional 
support and opportunities to share their experiences [26]. As a result, we might expect that 
patients and partners are more likely to rate support groups as helpful at 12-month follow-up 
compared to baseline. More research is needed to understand the useful components of 
Internet and face-to-face support groups. Importantly, since support groups have not been 
traditionally designed to address the needs of partners, more studies are needed to inform the 
development of support groups that incorporate the partner perspective and help couples 
navigate their treatment options.
A major strength of our study is the geographic representation in the multi-center study 
design, with study participants recruited from academic medical centers in CA, TX, and SC 
and recruiting patients early in their treatment decision-making process. Limitations were 
that study participants were predominantly non-Hispanic white and reported a higher than 
average education compared to the general population. Results, therefore, may not be 
representative of samples with greater racial/ethnic and socioeconomic diversity. In addition, 
patients were recruited through academic medical centers known for excellence in prostate 
cancer surgery. Hence, our study population may be enriched for men pursuing surgical 
treatment and may not be representative of all men with newly diagnosed localized prostate 
cancer. We did not collect data on the different types of information needs partners had and 
were not able to evaluate the content or quality of information gleaned from each 
information source.
Conclusion
Providing partners with balanced and accurate information designed to address their specific 
information needs is critical. In this survey, we found that partners consulted a large number 
of information sources in researching treatment options for local-stage prostate cancer, but 
there was no association between number of information sources used at baseline and 
satisfaction with care at 12-month follow-up. Some sources were viewed as less helpful to 
partners in retrospect, suggesting that additional resources to promote selection of high-
quality non-provider information sources may enable partners to better aid patients in their 
treatment decision-making process.
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Table 1
Partner demographic characteristics and information use at baseline
Partner characteristics Partners completing baseline 
survey (n = 179)
Partners completing 12-month 
follow-up survey (n = 93)a
Age at diagnosis
• 40–60 88 (49%) 38 (41%)
• 60–64 36 (20%) 24 (26%)
• 65–69 31 (17%) 20 (22%)
• 70–84 18 (10%) 10 (11%)
• Unknown 6 (3%) 1 (1%)
Race/ethnicity
• Non-Hispanic white 126 (70%) 72 (77%)
• Non-Hispanic black 21 (12%) 5 (5%)
• Hispanic 15 (8%) 9 (10%)
• Asian/Pacific Islander 12 (7%) 4 (4%)
• Other/unknown 5 (3%) 3 (3%)
Education
• High school 32 (18%) 12 (13%)
• Some college 61 (34%) 28 (30%)
• College graduate 57 (32%) 38 (41%)
• Graduate degree 28 (16%) 15 (16%)
• Unknown 1 (0%) 0 (0%)
Information source used at baseline
• Provider 177 (99%) 92 (99%)
• Literature (medical journals) 144 (80%) 75 (81%)
• Friends or family members 144 (78%) 75 (81%)
• Internet websites 116 (65%) 61 (66%)
• Books about prostate cancer 103 (56%) 52 (56%)
• Traditional media (newspaper, magazine, television, radio) 85 (37%) 46 (49%)
• Face-to-face or Internet support group 42 (26%) 15 (16%)
a
Partners completing the follow-up survey (n = 97) were a subset of those completing the baseline survey
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Table 3
Partner information sources rated as helpful at baseline and rated as recommended in the 12 month follow-up 
survey, among those who used each resource at baseline
Source % helpful at baseline 
(NHelpful/NPartners)
% recommended at 12 
months (NRecommended/
NPartners)
Odds ratio (95% CI) p value
Provider 97% (170/175) a a a
Literature 92% (132/144) 93% (70/75) 1.27 (0.42, 3.84) 0.669
Friends or family members 92% (132/144) 93% (70/75) 1.27 (0.42, 3.83) 0.668
Internet websites 90% (104/116) 82% (50/61) 0.52 (0.22, 1.25) 0.147
Books 87% (90/103) 62% (32/52) 0.23 (0.11, 0.49) <0.001b
Traditional media 75% (64/85) 61% (28/46) 0.51 (0.25, 1.02) 0.058
Face-to-face or Internet support 
group
52% (22/42) 87% (13/15) N/Ac N/Ac
a
Provider was not listed as an information source at 12 months
b
Italic font indicates statistically significant finding
c
These results were not included due to very small cell counts (2 of 15 partners did not recommend Internet or face-to-face support at 12 months)
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